READ-ONLY DIGITIZATION RESULT
Prognostic markers, quality of life (QoL) and value of health (V-He) in advanced biliary cancers (ABC) treated with second-line active symptom control (ASC) alone or ASC with oxaliplatin-5-FU chemotherapy (ASC + FOLFOX) in the randomised phase III, multicentre, open-label ABC-06 clinical trial.
ESMO Open · 2026-Jun-25 · PMID 42349245
Panel Overall_survival_by_raised_baseline_tumour_markers提取失败待 EXE 对齐验证
overall survival
Figure 1 OS by raised baseline tumour markers. CA19-9, carbohydrate antigen 19-9; CA125, cancer antigen 125; CEA, carcinoembryonic antigen; OS, overall survival.
算法:legacy-0.5.0引擎:enhanced-linux
No curves extracted
曲线数据
网页最多预览 200 行,完整数据请下载 CSV 或 JSON。
当前面板没有可预览的 `curves_mapped.csv` 数据。
历史版本(1)
重跑只新增版本,不覆盖旧结果;正式可用状态仅授予通过 EXE 基准或人工复核的版本。
| 版本 | 状态 | 验证 | 曲线 | 时间 |
|---|---|---|---|---|
| legacy-0.5.0 | failed | 待验证 | 0 | 2026-07-18T18:59:09+00:00 |